We assessed the long-term results of 58 Souter-Strathclyde total elbow replacements in 49 patients with rheumatoid arthritis. The mean length of follow-up was 9.5 years (0.7 to 16.7). The mean pre-operative Mayo Elbow Performance Score was 30 (15 to 80) and at final follow-up was 82 (60 to 95). A total of 13 elbows (22.4%) were revised, ten (17.2%) for aseptic loosening, one (1.7%) for instability, one (1.7%) for secondary loosening after fracture, and one elbow (1.7%) was removed because of deep infection. The Kaplan-Meier survival rate was 70% and 53% at ten and 16 years, respectively. Failure of the ulnar component was found to be the main problem in relation to the loosening. Anterior transposition of the ulnar nerve had no influence on ulnar nerve paresthaesiae in these patients.
Total elbow replacement is the treatment of choice for advanced arthropathy of the elbow joint. In patients with rheumatoid arthritis (RA) the post-operative clinical results of total elbow replacement are better than those of synovectomy, excision or interposition arthroplasty. The major advantage of replacement compared with arthrodesis is movement in the joint. [1] [2] [3] The Souter-Strathclyde total elbow prosthesis 4 (Howmedica Inc., Rutherford, New Jersey) was first used in our department in July 1988.
Patients and Methods
Between July 1988 and December 2000, 58 Souter-Strathclyde total elbow prostheses were inserted in 49 patients with RA. This was a consecutive series of patients with marked destruction of the elbow joint. Two were excluded because a long-stemmed humeral component had been used. Nine patients had a bilateral procedure. The mean duration of follow-up was 9.5 years (0.7 to 16.7). A total of 23 elbows were followed for more than ten years. There were 42 women and seven men with a mean age at operation of 53 years (22 to 71).
In eight elbows, a previous synovectomy with resection of the radial head had been performed a mean of 4.6 years (2.4 to 6.8) before total elbow replacement.
All patients were examined by one of the senior authors (IL) and were assessed both clinically and radiologically before the operation. Further examination was performed after one and two years, then at regular intervals of two years until final follow-up. The European League Against Rheumatism (EULAR) assessment chart 5 and the Mayo Elbow Performance Score 6 (Table I) were used to record the findings before and after operation.
We excluded from the review 13 total elbow prostheses, where a revision or removal of the prosthesis had been performed. Four patients (four elbows) died of unrelated causes at a mean of 9.45 years (3.84 to 12.81) after the operation. Their findings were included in the final evaluation. In total, 45 elbows (38 patients) were clinically assessed at the final follow-up.
The Kaplan-Meier method and life table were used to analyse the survival of the prostheses, with removal of the prosthesis (partial or whole) as the end-point. Surgical technique. The operation was performed under general anaesthesia by one of the three senior authors (IL, PV, AS) using the same technique. The patients were placed in a lateral position with the arm supported on a padded rest. A posterior approach was used in all cases. The posterior aponeurosis of the triceps was incised transversely between 8 cm and 10 cm above its insertion on the olecranon, and reflected downwards. The deep section of the triceps muscle was split longitudinally and the musculotendinous expansions on the medial and lateral sides of the elbow were reflected to the sides to access the epi-
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condyles. The ulnar nerve was visualised and decompressed in all cases to avoid damage during surgery by traction or by heat during cementing. The bony bed of the humeral and ulnar components was prepared using a high-speed air drill and burrs. When there was an extension deficit with the trial components, a soft-tissue release was carried out anteriorly. Both components were fixed with antibiotic-free Palacos bone cement (Schering-Plough, Kenilworth, New Jersey). No intramedullary plug was used. During reconstruction of the medial and lateral musculotendinous expansions, the lateral collateral ligament was tensioned by transosseous sutures in the area of the radial notch of the ulna prior to cementing. The ligament was strengthened by the lateral part of the annular ligament. The medial expansion and the partially-released posterior part of the ulnar collateral ligament were fixed in the medial corner of the proximal tip of the olecranon. Closure of the deep layers of the triceps muscle and dorsal aponeurosis followed. Anterior transposition of the ulnar nerve was carried out when pre-operative ulnar nerve paresthaesiae were apparent. Two suction drains were used for 48 hours. Prophylactic intravenous antibiotics were routinely employed for 24 hours.
A posterior backslab was used to maintain the elbow in 90˚ of flexion with neutral rotation of the forearm.
Passive and active flexion and extension exercises were started on the third day under the supervision of a physiotherapist. Between physiotherapy sessions the arm was supported in a posterior backslab for the first three weeks, after which it was worn only at night.
Results
Significant relief of pain was observed (paired t -test, p < 0.05). At the time of the latest follow-up, 35 (77.7%) of the 45 elbows had no pain, seven (15.6%) had mild occasional pain with loading or stress, and three (6.7%) had moderate pain with loading and sometimes at rest.
The range of flexion, pronation and supination increased significantly (Table II) . Previous surgery on the elbow did not significantly influence the range of movement (p = 0.36).
Routine daily activity can be carried out with 30˚ to 130o f elbow flexion and 50˚ of pronation and supination. Only 15 elbows (33.3%) had flexion of more than 110˚ at the time of the last follow-up. The remaining 30 elbows had flexion of less than 110˚.
The Mayo elbow performance score increased from a mean of 30 (15 to 80) pre-operatively to 82 (60 to 95) at final follow-up. Before operation there were ulnar nerve paresthaesiae in ten forearms and these persisted after anterior transposition of the nerve. After operation, there were paresthaesiae in eight additional forearms, six of which were transient and two persistent. In three cases transient radial palsy was detected.
Four post-operative instabilities (6.9%) were observed. All dislocations occurred in the first three months after surgery. These patients were intially treated with open reduction followed by two weeks of immobilisation in a plaster cast. This was not successful. In three unstable elbows the components were in the correct position. External fixation was used in these cases to manage the instability after open reduction with the hinge strictly aligned with the axis of movement. Rehabilitation was carried out without restrictions regarding the range of movement. The external fixator was removed after six weeks in all cases. None of these patients had further dislocations. In the fourth elbow with instability the humeral component was in the varus position. It was revised and replaced by a floppy hinge prosthesis.
Radiographs were taken of all patients at the time of the final follow-up. Five (11.1%) elbows had a radiolucent line more than 1 mm in width around the whole ulnar compo- ). These were apparent around the distal part of the implant in the area of lateral flange. All these radiolucent lines were less than 1 mm wide. The patients with radiolucent lines on radiographs did not have symptoms and revision was not indicated. The total elbow prosthesis was revised in 13 (22.4%) of the original 58 elbows. There were ten (17.2%) elbows with aseptic loosening of one or both components. The ulnar components were loose in all cases, and the humeral implants in two (Fig. 1) . In the other four cases where humeral components were removed, extensive osteolysis was present without migration of the prosthesis. Postoperative fracture of the distal part of the humerus with secondary loosening was the reason for revision in one (1.7%) case and instability in another (1.7%). One implant was removed because of deep infection. Implant survival was assessed by Kaplan-Meier analysis (Fig. 2) . The survival rate was 70% and 53% at ten and 16 years, respectively. The life table was also used for clarification (Table  III) . There was no statistical difference between the basic analysis with removal of the prosthesis (partial or whole) as the end-point and the worst-case analysis with removal of the prosthesis or radiological loosening as the end-point (p = 0.48) (Fig. 2) .
Discussion
In our group of patients, pain relief, range of movement and Kaplan-Meier survival rates are comparable with those described in other papers. [7] [8] [9] [10] Loosening of the implant is the main complication. High rates of loosening in the humeral component have been descrbed in the literature. 7, 9, 10 Valstar, Garling and Rozing 11 presumed that it was due to micromovement. Some authors believe that a long-stemmed humeral component is better regarding loosening. 10, 11 Our experience is different. We have encountered extensive loosening of the humeral component in only two cases (Fig. 1) ; the ulnar components were initially loose in most cases of aseptic loosening. The humeral components showed some osteolysis without migration.
The indication for revising both components was extensive loss of ulnar and humeral bone stock causing instability. The long-stemmed floppy hinge prosthesis was used for revision.
In all revised elbows the ulnar component was heavily damaged or fractured. Failure of the ulnar component appears to be the primary problem perhaps due to the difference between the elasticity of the polyethylene ulnar component and the cement layer which may fracture. This initiated the change of design to metal-backed components. Ikavalko et al 12 presumed that polyethylene debris and micromovement of the all-polyethylene component causes progressive loosening of the stem more often than with a rigid metal-backed component. The dislocation rate of 6.7% was slightly higher than in other reports. [7] [8] [9] [10] When tensioning of the collateral ligaments is difficult a metal-backed snap-fit component is recommended. We have used this component for revisions of the ulnar component, unstable traumatic elbows with large bone defects and instability. The use of the snap-fit variant of the ulnar component has no influence on implant survival. 12 If there is instability in spite of correct component positioning, external fixation can be used. This is a simple method to temporarily stabilise the unstable elbow replacement. Its advantage is that it allows essential exercise and physiotherapy in the first six weeks.
Our rate of infection (1.7%) is comparable with that reported elsewhere. 7, 10, 13 We therefore think that using bone cement with antibiotics is unnecessary.
The three transient radial nerve palsies in our series might be caused by traction due to the positioning during the procedure. In patients with cubital tunnel syndrome we usually perform an anterior transposition. Our experience is in accordance with the opinion of Kleinman, 14 who states that anterior transposition eliminates any potential postoperative nerve dysfunction due to persistent tension or compression. Anterior transposition of the ulnar nerve had little influence in our patients. We share the opinion of Pöll 5 regarding the possibility of a pre-existing subclinical neuropathy of the ulnar nerve in patients with RA due to mechanical or vascular causes. According to Pöll, 5 careful visualisation and decompression of the ulnar nerve is recommended in rheumatoid elbows.
Although a technically demanding procedure, the SouterStrathclyde prosthesis is a viable option for the treatment of destructive arthropathy of the elbow caused by RA. Meticulous surgical technique with good component positioning and collateral ligament balancing is essential for long-term survival. The main challenge appears to be the allpolyethylene design of the ulnar component and its wear. Anterior transposition of the ulnar nerve has no influence on ulnar nerve neuropathy in patients with RA.
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